top glp-1 companies TrimRX GLP-1 Agonists Market Growth to
Description
This study explores real-world outcomes of oral semaglutide (GLP-1 receptor agonist) in Indian patients with Type 2 Diabetes Mellitusan area where data remain limited in India
2022;10(4):e00962
This shift in usage patterns suggests these drugs are no longer solely reserved for managing severe metabolic conditions but are becoming a broader tool in preventive strategies
As part of phase-1 launch, we aim to introduce generic semaglutide in several countries and, through our One Product, One Quality approach, we are committed to ensure the same highquality product across all markets. M.V
